Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Aminex Therapeutics, Inc.
March 6, 2026
Aminex Therapeutics, Inc.
Orphan Drug Designation
Kenmore
1-50 employees
prevention of allograft rejection in liver transplantation
Disease Area:
Rare Disease
Source
March 5, 2026
Aminex Therapeutics, Inc.
Orphan Drug Designation
Kenmore
1-50 employees
treatment of malignant glioma
Disease Area:
Rare Disease
Source
Scroll to Top